rs1061502
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001572.5(IRF7):c.535A>G(p.Lys179Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.271 in 1,610,258 control chromosomes in the GnomAD database, including 64,369 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Synonymous variant affecting the same amino acid position (i.e. K179K) has been classified as Likely benign.
Frequency
Consequence
NM_001572.5 missense
Scores
Clinical Significance
Conservation
Publications
- immunodeficiency 39Inheritance: AR Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IRF7 | NM_001572.5 | c.535A>G | p.Lys179Glu | missense_variant | Exon 6 of 11 | ENST00000525445.6 | NP_001563.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.325 AC: 49409AN: 151960Hom.: 9392 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.253 AC: 61686AN: 243768 AF XY: 0.242 show subpopulations
GnomAD4 exome AF: 0.265 AC: 386586AN: 1458180Hom.: 54961 Cov.: 41 AF XY: 0.261 AC XY: 188953AN XY: 725208 show subpopulations
GnomAD4 genome AF: 0.325 AC: 49460AN: 152078Hom.: 9408 Cov.: 33 AF XY: 0.315 AC XY: 23381AN XY: 74340 show subpopulations
ClinVar
Submissions by phenotype
Immunodeficiency 39 Benign:2
- -
- -
not provided Benign:1Other:1
- -
Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. -
not specified Benign:1
This variant is classified as Benign based on local population frequency. This variant was detected in 59% of patients studied by a panel of primary immunodeficiencies. Number of patients: 56. Only high quality variants are reported. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at